Condition: Glioma, Malignant · Glioblastoma · Glioblastoma Multiforme · Sponsor: Northwell Health
This single center, single arm, open-label, phase 2 study will assess the safety and efficacy of a pedicled temporoparietal fascial (TPF) or pericranial flap into the resection cavity of newly diagnosed glioblastoma multifome (GBM) patients. The objective of the Phase 2 study is to demonstrate that this surgical technique is safe and effective in a human cohort of patients with resected newly diagnosed AA or GBM and may improve progression-free survival (PFS) and overall survival (OS).
This description comes directly from the study's public registry record.
John Boockvar, MD · 212-434-3900 · jboockvar@northwell.edu
Tamika Wong, MPH · 212-434-4836 · twong4@northwell.edu
Always discuss trial participation with your own doctor first.
| Lenox Hill Brain Tumor Center | New York, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05954858